A ground glass opacity on a CT scan is not always cancer. The term describes a hazy, translucent area in the lung where the underlying structures remain partially visible, and it can be caused by infections, inflammation, fluid buildup, autoimmune disease, or even technical artifacts from the scan itself. That said, persistent GGOs do carry a meaningful chance of being a precancerous or cancerous lesion, which is why doctors take them seriously and recommend follow-up imaging. The relationship between GGOs and cancer is real but far more nuanced than a one-to-one link, and understanding where you fall on that spectrum matters for what happens next.
What a Ground Glass Opacity Actually Is
On a CT scan, normal lung tissue looks dark because it is mostly filled with air. A ground glass opacity appears as a lighter, foggy patch where the tissue is partially filled with something other than air, but not so dense that it completely blocks the view of blood vessels and airways behind it. That “something” could be fluid, inflammatory cells, early scar tissue, or abnormal cell growth. The term is purely descriptive and says nothing about the cause. Radiologists use it the way you might describe a smudge on a window: it tells you something is there, not what made it.
GGOs can result from changes in either the air spaces of the lung or the tissue between them.1Journal of Thoracic Imaging. Computed Tomography Assessment of Ground-Glass Opacity: Semiology and Significance This is why the list of possible diagnoses is so long. Anything that partially fills the tiny air sacs or thickens the walls around them can produce the same hazy look on a scan.
The Many Non-Cancer Causes
Infections are probably the most common reason a GGO shows up unexpectedly. Viral pneumonias, including COVID-19, frequently produce ground glass patterns on chest CT. Bacterial and fungal infections can do the same. In the context of an active infection, GGOs often appear in both lungs, in multiple patches, and they tend to resolve as the infection clears.2PubMed Central. Ground-glass opacity (GGO): a review of the differential diagnosis in the era of COVID-19
Beyond infections, a range of other conditions produce GGOs:
- Pulmonary edema: fluid backup in the lungs from heart failure or fluid overload.
- Alveolar hemorrhage: bleeding into the air sacs, which can happen with certain autoimmune disorders or clotting problems.
- Hypersensitivity pneumonitis: an allergic-type lung reaction to inhaled particles like mold, bird droppings, or certain chemicals.
- Nonspecific interstitial pneumonia: a form of chronic lung inflammation often linked to autoimmune diseases.
- Pulmonary alveolar proteinosis: a rare condition where protein-rich material accumulates in the air sacs.
All of these can appear as GGO on imaging.3Current Problems in Diagnostic Radiology. Clear Vision Through the Haze: A Practical Approach to Ground-Glass Opacity In some cases, the GGO is the first clue that something treatable is going on, and the haziness disappears entirely once the underlying problem is addressed.
Vaping-related lung injury has also become a recognized cause. Electronic cigarette or vaping product use-associated lung injury typically shows up as ground glass opacity and areas of denser consolidation across multiple lobes of both lungs, sometimes with characteristic sparing of the tissue right next to the lung surface. Most patients improve after they stop vaping and receive steroid treatment.4PubMed Central. Pulmonary Injury Resulting from Vaping or e-Cigarette Use: Imaging Appearances at Presentation and Follow-up
Transient Versus Persistent GGOs
One of the most important distinctions doctors make is whether a GGO sticks around. A large proportion simply vanish on a follow-up scan done weeks or months later. In one study of solitary GGO lesions, roughly 38% of pure GGOs and about 49% of mixed GGOs (those with both hazy and solid parts) had shrunk or disappeared entirely by the time of the next scan.5Lung Cancer. Clinical significance of a solitary ground-glass opacity (GGO) lesion of the lung detected by chest CT These transient GGOs are almost always caused by infections or inflammation that resolved on their own.
Persistent GGOs, the ones that remain stable or grow over months, are the ones that warrant closer attention. A GGO that is still present after three months is much more likely to represent a precancerous change or an early-stage cancer than one that fades away. This is why the standard approach to a new, incidentally discovered GGO is not to biopsy it immediately but to repeat the scan after a period of time and see what happens.
When a Persistent GGO Is Cancer
Among persistent GGOs that are eventually biopsied or surgically removed, a significant proportion do turn out to be neoplastic. In one study of 53 persistent ground glass nodules that went to surgery, about three-quarters proved to be a form of lung adenocarcinoma, roughly 6% were a precancerous overgrowth called atypical adenomatous hyperplasia, and about 19% were benign findings like fibrosis or organizing pneumonia.6PubMed. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons That 75% figure sounds alarming, but keep in mind these were nodules persistent enough and suspicious enough to be removed surgically, which introduces selection bias. The overall population of people with GGOs on a scan includes all the transient ones that disappear.
GGO-associated cancers typically exist on a spectrum. At one end sit precancerous lesions like atypical adenomatous hyperplasia, which appear as small, faint pure GGOs. A step further along is adenocarcinoma in situ, a non-invasive cancer that has not yet broken through the basement membrane of the airway lining. Both of these tend to show up as pure ground glass, with no solid component visible.7PubMed Central. Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected? More advanced forms of adenocarcinoma, including minimally invasive adenocarcinoma and fully invasive types, tend to develop a visible solid component within the GGO. The density on CT also tends to increase as the lesion progresses: one study found the average density of atypical adenomatous hyperplasia was around -718 Hounsfield units, compared to about -600 for adenocarcinoma in situ, a measurable and statistically significant difference.8PubMed Central. The Value of CT Attenuation in Distinguishing Atypical Adenomatous Hyperplasia from Adenocarcinoma in Situ
Extremely Slow Growth
Even when a GGO does represent cancer, these tumors are overwhelmingly slow-growing compared to other lung cancers. Pure ground glass nodules that grow have a median volume doubling time reported at roughly 769 days in one screening study9Chest. Natural History of Pure Ground-Glass Opacity Lung Nodules Detected by Low-Dose CT Scan and about 1,448 days in another long-term follow-up.10PubMed. Long-term follow-up of persistent pulmonary pure ground-glass nodules with deep learning-assisted nodule segmentation That is anywhere from roughly two to four years for the volume to double. For context, aggressive solid lung cancers can double in weeks to months. This glacial pace is one reason surveillance imaging works well for GGOs: there is usually plenty of time to catch progression before it becomes dangerous.
Case reports have documented this indolent behavior over remarkably long periods. One case followed a pure GGO nodule for more than ten years as it gradually evolved from a presumed precancerous lesion into an invasive adenocarcinoma.11Lung Cancer. Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: An observation for more than 10 years Another patient’s PET-negative ground glass nodule slowly transitioned to a mixed lesion over nine years before being confirmed as adenocarcinoma.12PubMed Central. Indolent Progression of a Persistent Positron Emission Tomography (PET)-Negative Ground-Glass Pulmonary Nodule to Pulmonary Adenocarcinoma Following Nine Years of Radiographic Surveillance: A Case Report Even among nodules that had been stable for five years, some eventually developed growth or a new solid component, reinforcing that long-term follow-up remains reasonable.13Journal of Thoracic Oncology. Long-Term Follow-Up of Ground-Glass Nodules After 5 Years of Stability
How Doctors Assess Cancer Risk on the Scan
Radiologists look at several features to judge how suspicious a GGO appears. A well-defined but coarse boundary, a round or oval shape, location in an upper lobe, and the presence of a centrally distributed solid component all push the probability of malignancy higher.14PubMed Central. Differential diagnosis of benign and malignant patchy ground-glass opacity by thin-section computed tomography Lobulation, pleural indentation (where the lung surface gets pulled inward toward the nodule), and convergence of blood vessels toward the lesion are additional red flags.15British Journal of Radiology. Multidetector CT features of pulmonary focal ground-glass opacity: differences between benign and malignant
Size matters too. GGOs larger than 10 mm are significantly more likely to grow, as are those that already contain a solid component. A prior history of lung cancer is another independent risk factor.16PubMed. Pulmonary ground-glass opacity (GGO) lesions-large size and a history of lung cancer are risk factors for growth Patient demographics also play a role. One retrospective study found that older age, female sex, and Asian race were all independently associated with a higher likelihood that a suspicious GGO would turn out to be adenocarcinoma.17PubMed Central. Risk of adenocarcinoma in patients with a suspicious ground-glass opacity: a retrospective review
None of these features is definitive on its own. Even clear-cut margins, one of the strongest imaging predictors of malignancy, sometimes show up in benign GGOs.18PubMed. Differential diagnosis and management of focal ground-glass opacities Diagnosis almost always depends on combining imaging characteristics with clinical context: Is the patient a smoker? Was there a recent infection? Is the GGO new or has it been there for years?
Why PET Scans Are Often Unhelpful for GGOs
PET scans, which detect areas of high metabolic activity and are a mainstay of cancer staging for many tumor types, perform poorly with ground glass lesions. GGO-predominant cancers are so metabolically quiet that they frequently do not light up on a PET scan the way a typical solid lung cancer would.19PubMed. Is there a role for FDG PET in the management of lung cancer manifesting predominantly as ground-glass opacity? This is partly because these tumors grow so slowly and have so little solid tissue that they do not consume enough glucose to cross the detection threshold. The detection rate improves somewhat for larger GGOs with a more prominent solid component, but for small or pure ground glass nodules, PET adds little useful information.20PubMed Central. Application of positron emission tomography-computed tomography in the diagnosis of pulmonary ground-glass nodules A negative PET scan, in other words, does not rule out cancer when the lesion is a GGO. This catches some patients off guard: they expect a PET scan to settle the question, but with GGOs, a CT-based watch-and-wait approach is usually more informative.
Biopsy Limitations
Biopsying a GGO is technically harder than biopsying a solid nodule. The lesion is faint and partially translucent, making it difficult to confirm the needle is in the right spot. And even when the biopsy succeeds, the tissue sample can underestimate how invasive the lesion really is. In one study of CT-guided needle biopsies of small GGO-containing lesions, the diagnostic accuracy was about 93%, which sounds good, but the degree of invasion was underestimated in roughly 44% of cases compared to what was ultimately found at surgery. For pure GGOs specifically, the underestimation rate was even higher, reaching about 83%.21Journal of Thoracic Oncology. Percutaneous Computed Tomography-Guided Coaxial Core Biopsy for Small Pulmonary Lesions with Ground-Glass Attenuation Complications like small pneumothorax and mild hemoptysis (coughing up a small amount of blood) occurred in roughly half and a fifth of patients, respectively. For these reasons, biopsy is not always the first step. Many clinicians prefer serial imaging, especially for pure GGOs, and reserve biopsy or surgery for lesions that grow or develop a solid component.
What the Follow-Up Guidelines Recommend
The Fleischner Society, an international group of thoracic radiologists, has published widely adopted guidelines for managing incidentally discovered lung nodules, including specific recommendations for subsolid (ground glass and part-solid) nodules.22PubMed. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society The updated 2017 guidelines raised the threshold size at which follow-up imaging is recommended and emphasized that nodule shape, density, and patient risk factors all matter as much as raw size.23PubMed. Updated Fleischner Society Guidelines for Managing Incidental Pulmonary Nodules: Common Questions and Challenging Scenarios
In general, the approach for a solitary pure GGO under 6 mm is usually no follow-up needed at all. For pure GGOs at or above 6 mm, a follow-up CT at 6 to 12 months is typical, with continued surveillance every two years if it persists. Part-solid nodules (those with both ground glass and solid components) get somewhat more aggressive follow-up because the solid part raises concern for invasive cancer. If the solid component is 6 mm or larger and persists, PET scanning or tissue sampling may enter the conversation, though as noted above, PET has limitations here. Individual management is the guiding principle: a GGO in a 35-year-old non-smoker with a recent respiratory infection calls for a very different approach than the same-looking nodule in a 65-year-old with a smoking history.24PubMed. Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017
Surgical Outcomes When It Is Cancer
If a GGO-predominant lesion does turn out to be cancer and surgery is recommended, the prognosis is remarkably good. Because these tumors are typically caught at a very early stage, smaller operations that remove less lung tissue can be as effective as larger ones. For GGO-dominant tumors 2 cm or smaller, wedge resection or segmentectomy (removing just a small wedge or segment of the lung rather than an entire lobe) shows excellent results.25PubMed Central. Surgical Extent for Ground Glass Nodules One study comparing lobectomy, segmentectomy, and wedge resection for GGO-dominant stage IA lung adenocarcinoma found no significant difference in three-year recurrence-free survival among the three approaches, with all exceeding 92%.26Chest. Appropriate Sublobar Resection Choice for Ground Glass Opacity-Dominant Clinical Stage IA Lung Adenocarcinoma: Wedge Resection or Segmentectomy
A prospective study that followed patients for a full ten years after sublobar resection for GGO-dominant lung cancer found zero recurrences during the entire follow-up period, with disease-specific survival of 100% and overall survival above 96%.27Scientific Reports. A prospective 10-year follow-up study after sublobar resection for ground-glass opacity-dominant lung cancer These numbers are dramatically better than what you see with solid, more aggressive lung cancers and reflect the fundamentally different biology of GGO-predominant tumors.
The Overdiagnosis Problem
The flip side of excellent survival numbers is a growing concern that many GGOs flagged by CT screening may never progress to clinically meaningful cancer within a person’s lifetime. Because these lesions grow so slowly, some of them would remain harmless even if left entirely alone. This creates what researchers call overdiagnosis: labeling someone with a cancer diagnosis and potentially treating a tumor that would never have caused symptoms or shortened their life.28PubMed. Overdiagnosis and overtreatment of ground-glass nodule-like lung cancer
The anxiety that comes with being told you have a lung nodule is real and well-documented. People spend months between scans wondering whether their GGO is growing or turning into something dangerous. For some, the psychological burden of surveillance may outweigh the actual medical risk posed by a tiny, stable, pure GGO. This is not an argument against follow-up, which remains the right call for many patients, but it is a reason to have an honest conversation with your doctor about where your specific nodule falls on the risk spectrum rather than assuming the worst.
Technical Factors That Can Create or Obscure GGOs
Not every GGO on a CT scan reflects a real abnormality in the lung. The way the scan is performed can influence whether a GGO appears and how it looks. Slice thickness is one key variable: using thicker slices (3 mm or above) can blur the edges of a nodule, making it look more like ground glass when it might actually be partly solid, or causing small nodules to be missed or misclassified entirely.29PubMed. Optimal image reconstruction for detection and characterization of small pulmonary nodules during low-dose CT Thin-section CT, typically 1 to 1.5 mm, gives a much more accurate picture. Breathing motion during the scan, patient positioning, and even transient changes like mild fluid retention can produce areas of ground glass that are not there on a repeat study. This is one more reason follow-up imaging is the default strategy: the first scan may be misleading.
Artificial Intelligence and the Future of GGO Assessment
Machine learning models are being developed to help radiologists predict whether a ground glass nodule is invasive cancer or a pre-invasive lesion. One recent model that combined imaging texture features, deep-learning-extracted features, and other data achieved an accuracy of about 80% on an external validation set for distinguishing invasive adenocarcinoma from pre-invasive lesions.30Academic Radiology. Explainable Machine Learning for Predicting Invasiveness of Pulmonary Adenocarcinoma Presenting as Ground-Glass Nodules Using CT Images Another multicenter study using a different machine learning approach reported similar performance, though the researchers cautioned that results for pure GGOs specifically were based on small numbers and should be considered exploratory.31Scientific Reports. Interpretable machine learning for preoperative prediction of ground-glass nodules invasiveness in lung adenocarcinoma: a multicenter study
AI-assisted analysis of histogram features from CT scans, looking at the distribution of density values within a nodule, is another avenue showing promise. One study found that the average CT density value and the volume of solid components within a GGO were both independently associated with the lesion being adenocarcinoma.32PubMed Central. Artificial intelligence system-based histogram analysis of computed tomography features to predict tumor invasiveness of ground-glass nodules These tools are not yet standard clinical practice, but they point toward a future where the uncertainty that currently accompanies a GGO finding could be reduced without resorting to invasive procedures. For now, though, the combination of skilled radiologist interpretation, clinical context, and serial imaging remains the backbone of GGO management.
GGOs in Autoimmune and Fibrotic Lung Disease
Ground glass opacity takes on a different significance when it appears in someone with a known autoimmune condition like systemic sclerosis (scleroderma). In that context, GGO often reflects active inflammation in the lung tissue, but it can also represent early fibrosis. A long-term follow-up study of systemic sclerosis patients found that ground glass opacity improved in only about 5% of cases and was most commonly associated with irreversible disease.33Journal of Thoracic Imaging. Significance of Ground-glass Opacity on HRCT in Long-term Follow-up of Patients With Systemic Sclerosis This is a very different clinical picture from the isolated incidental GGO found on a screening scan. Here, the concern is not cancer at all but progressive scarring that can impair lung function over time. The same CT finding, ground glass opacity, points toward entirely different diagnoses and management plans depending on who the patient is and what else is going on.